Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists (Q42536290)

1 November 2017

title

Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists (English)

1 reference

1 November 2017

Chambers RJ

1

1 reference

1 November 2017

Antognoli GW

2

1 reference

1 November 2017

Cheng JB

3

1 reference

1 November 2017

Kuperman AV

4

1 reference

1 November 2017

Liston TC

5

1 reference

1 November 2017

Marfat A

6

1 reference

1 November 2017

Owens BS

7

1 reference

1 November 2017

Pillar JS

8

1 reference

1 November 2017

Shirley JT

9

1 reference

1 November 2017

Watson JW

10

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

1 November 2017

published in

1 reference

1 November 2017

volume

8

1 reference

1 November 2017

issue

24

1 reference

1 November 2017

page(s)

3577-3582

1 reference

1 November 2017

cites work

Eicosanoids and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

1 reference

7 January 2021

A phosphorylation of steroids and a dienone-phenol rearrangement leading to a secosteroidal aldehyde which has a strong toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Metabolism of gentiopicroside (gentiopicrin) by human intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Development of new chromanol antagonists of leukotriene D4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: Metabolite identification by gas chromatography mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Rules for ring closure: ring formation by conjugate addition of oxygen nucleophiles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Oxidation of Activated Halides to Aldehydes and Ketones by N-Methylmorpholine-N-oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

Influx of extracellular calcium is required for the membrane translocation of 5-lipoxygenase and leukotriene synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900654-4

7 January 2021

10.1016/S0960-894X(98)00654-4

Identifiers

DOI

1 reference

1 November 2017

1 reference